Stock: IEX Surpasses Q4 CY2025 Earnings, Beating Market Expectations

[Para 1: The Lead] IDEX (NYSE:IEX) exceeded Q4 CY2025 earnings, surpassing Wall Street revenue forecasts. Sales climbed 4.2% annually to $899.1 million, and non-GAAP earnings per share of $2.10 surpassed analyst consensus by 2.9%. The stock closed flat at $201.66 post-results. [Para 2-3: Supporting details & Context] IDEX, a global manufacturer, reported modest year-over-year revenue growth of 4.2% but outperformed earnings expectations. Analysts anticipate 2.2% revenue growth over the next 12 months, similar to its two-year trend. IDEX's organic revenue was flat over the last two years, indicating acquisitions and foreign exchange impacts boosted headline results. The company's operating margin improved to 20.4% from 19.1% in Q4 CY2024, signaling expense efficiency. Wall Street expects full-year EPS of $7.95 to grow 4.5% in the next 12 months. Despite positive earnings, IDEX's guidance for the next quarter missed, and full-year EPS guidance was slightly below market estimates. The stock's performance suggests a mixed quarter, with key positives in revenue and earnings per share, but concerns over guidance.